Envista Holdings Corp NVST
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. 10-K, Item 1
- Headquarters
- Brea, CA
- CEO
- Paul A. Keel
- Next results
- around Feb 4, 2027
Where each dollar of revenue went, FY2025
Revenue of $2.7B through the costs to a net profit of $47.0M · income statement of the 10-K
NVST among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
1 new risk paragraph and 2 accounting facts worth reading about. 10-K filed Feb 12, 2026 against Feb 13, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
2facts worth reading about the other 9 checks found nothing to note
-
Receivables growing faster than revenueReceivables +18.3% ($363.0M to $429.6M) vs revenue +8.3% ($2.5B to $2.7B), +10.0 pts apart
-
Inventory growing faster than revenueInventory +19.5% ($241.0M to $288.1M) vs revenue +8.3% ($2.5B to $2.7B), +11.2 pts apart
-
Cash from operations $275.7M vs net income $47.0M (FY ending Dec 31, 2025)
8 more checks with nothing to note
-
Same auditor in both 10-Ks: Ernst & Young LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Goodwill Impairment; Indefinite-lived Intangible Asset Impairment
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
1 paragraph in Risk Factors that was not in the 10-K filed Feb 13, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
We are also subject to various laws regulating fraud and abuse, pricing and sales and marketing practices in the health care industry and the privacy and security of health information as well as manufacturing and quality standards, including the federal regulations described in “Item 1. Business —Regulatory Matters.” Ensuring that our…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $2.6B | $2.6B | $2.5B | $2.7B |
| Net income | $243.1M | −$100.2M | −$1.1B | $47.0M |
| Operating cash flow | $182.7M | $275.7M | $336.5M | $275.7M |
| Free cash flow | $107.0M | $217.5M | $302.7M | $230.4M |
Revenue, FY2017 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$2.7B ▲ 8.3% in FY2025$47.0M in FY2025$230.4M ▼ 23.9% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
8-KNov 4, 2026Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
-
10-QNov 4, 2026Quarterly report (10-Q) period ended Oct 2, 2026
-
8-KOct 27, 2026Regulation FD disclosure 8-K item 7.01
About the company
Envista Holdings Corp, Brea, CA · from the 10-K filed Feb 12, 2026
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile.
- Headquarters
- Brea, CA
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Nov 4, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed Feb 12, 2026 (open at SEC), compared with the 10-K filed Feb 13, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NVST/export.csv") into a cell.